Participatory Design of a Clinical Trial Eligibility Criteria Simplification Method

被引：5

作者：

Fang, Yilu ^{[1
]}

Kim, Jae Hyun ^{[1
]}

Idnay, Betina Ross ^{[2
,3
]}

Garcia, Rebeca Aragon ^{[3
]}

Castillo, Carmen E. ^{[3
]}

Sun, Yingcheng ^{[1
]}

Liu, Hao ^{[1
]}

Liu, Cong ^{[1
]}

Yuan, Chi ^{[1
]}

Weng, Chunhua ^{[1
]}

机构：

[1] Columbia Univ, Dept Biomed Informat, New York, NY USA

[2] Columbia Univ, Sch Nursing, New York, NY USA

[3] Columbia Univ, Dept Neurol, New York, NY USA

来源：

PUBLIC HEALTH AND INFORMATICS, PROCEEDINGS OF MIE 2021 | 2021年 / 281卷

关键词：

named entity recognition; concept mapping; intelligence augmentation;

D O I：

10.3233/SHTI210325

中图分类号：

TP39 [计算机的应用];

学科分类号：

081203 ; 0835 ;

摘要：

Clinical trial eligibility criteria are important for selecting the right participants for clinical trials. However, they are often complex and not computable. This paper presents the participatory design of a human-computer collaboration method for criteria simplification that includes natural language processing followed by user-centered eligibility criteria simplification. A case study on the ARCADIA trial shows how criteria were simplified for structured database querying by clinical researchers and identifies rules for criteria simplification and concept normalization.

引用

页码：984 / 988

页数：5

共 50 条

[31] Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
Outtier, An
Janssens, Rosanne
Barbier, Liese
Sabino, Joao
Verstockt, Bram
Vermeire, Severine
Huys, Isabelle
Ferrante, Marc
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024,
[32] Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design
Jie Xu
Hao Zhang
Hansi Zhang
Jiang Bian
Fei Wang
Scientific Reports, 13 (1)
[33] Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design
Xu, Jie
Zhang, Hao
Zhang, Hansi
Bian, Jiang
Wang, Fei
SCIENTIFIC REPORTS, 2023, 13 (01):
[34] The Problem of Restrictive Thrombectomy Trial Eligibility Criteria
Nguyen, Thanh N.
Raymond, Jean
Nogueira, Raul G.
Fischer, Urs
Siegler, James E.
STROKE, 2022, 53 (09) : 2988 - 2990
[35] Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
Muneer J. Al-Husseini
Anas M. Saad
Hadeer H. Mohamed
Mohamad A. Alkhayat
Mohamad Bassam Sonbol
Omar Abdel-Rahman
BMC Cancer, 19
[36] OWL model of clinical trial eligibility criteria compatible with partially-known information
Olivier Dameron
Paolo Besana
Oussama Zekri
Annabel Bourdé
Anita Burgun
Marc Cuggia
Journal of Biomedical Semantics, 4
[37] Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
Sun, Xuqi
Li, Lingling
Xu, Li
Zhou, Zhongguo
Chen, Jinbin
Wang, Juncheng
Zhang, Yaojun
Hu, Dandan
Chen, Minshan
BMC CANCER, 2021, 21 (01)
[38] Transformer-Based Named Entity Recognition for Parsing Clinical Trial Eligibility Criteria
Tian, Shubo
Erdengasileng, Arslan
Yang, Xi
Guo, Yi
Wu, Yonghui
Zhang, Jinfeng
Bian, Jiang
He, Zhe
12TH ACM CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS (ACM-BCB 2021), 2021,
[39] Mapping Real-World Psoriatic Arthritis Patients to Clinical Trial Eligibility Criteria
Arendse, Regan
Haaland, Derek
Fortin, Isabelle
Rahman, Proton
Rampakakis, Emmanouil
Asin-Milan, Odalis
Rachich, Meagan
Nantel, Francois
Lehman, Allen
JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1035 - 1036
[40] MAPPING REAL-WORD PSORIATIC ARTHRITIS PATIENTS TO CLINICAL TRIAL ELIGIBILITY CRITERIA
Arendse, Regan
Haaland, Derek
Fortin, Isabelle
Rahman, Proton
Rampakakis, Emmanouil
Asin-Milan, Odalis
Rachich, Meagan
Nantel, Francois
Lehman, Allen J.
INTERNAL MEDICINE JOURNAL, 2020, 50 : 10 - 10

← 1 2 3 4 5 →